Duration of, and temporal trends (1994-1997) in, prehospital delay in patients with acute myocardial infarction: The second National Registry of Myocardial Infarction

Archives of Internal Medicine

Volumn 159, Issue 18, 1999, Pages 2141-2147

  Goldberg, Robert J ^a,b   Gurwitz, Jerry H ^a,b   Gore, Joel M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ARTICLE; CORONARY ARTERY DILATATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICAL CARE; MEDICAL RECORD; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; QUALITY CONTROL; REPERFUSION INJURY; RISK ASSESSMENT; SYMPTOMATOLOGY;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT ADMISSION; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 0033547236     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.18.2141     Document Type: Article

References (24)

1. Grines CL, DeMaria AN. Optimal utilization of thrombolytic therapy for acute myocardial infarction: concepts and controversies. J Am Coll Cardiol. 1990;16:223-231.
2. Yusuf S, Collins R, Peto R, et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction, and side effects from 33 randomized controlled trials. Eur Heart J. 1985;6:556-585.
3. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet. 1994;343:311-322.
4. Holmes DR Jr, Califf RM, Topol EJ. Lessons we have learned from the GUSTO trial: global utilization of streptokinase and tissue plasminogen activator for occluded arteries. J Am Coll Cardiol. 1995;25(suppl):10S-17S.
5. Newby LK, Rutsch WR, Califf RM, et al. Time from symptom onset to treatment and outcomes after thrombolytic therapy: GUSTO-1 investigators. J Am Coll Cardiol. 1996;27:1646-1655.
6. Dracup K, Moser DK. Treatment-seeking behavior among those with signs and symptoms of acute myocardial infarction. Heart Lung. 1991;20:570-575.
7. Dracup K, Moser DK, Eisenberg M, Meischke H, Alonzo AA, Braslow A. Causes of delay in seeking treatment for heart attack symptoms. Soc Sci Med. 1995;40: 379-392.
8. Ho MT. Delays in the treatment of acute myocardial infarction: an overview. Heart Lung. 1991;20:566-569.
9. LaRosa JH, Horan MJ, Passamani ER, eds. Proceedings of the National Heart, Lung and Blood Institute Symposium on Rapid Identification and Treatment of Acute Myocardial Infarction: Issues and Answers. Rockville, Md: National Heart, Lung, & Blood Institute, National Institutes of Health, US Dept of Health & Human Services; 1991:1-157.
10. Rogers WJ, Bowlby LJ, Chandra NC, et al. Treatment of myocardial infarction in the United States (1990 to 1993): observations from the National Registry of Myocardial Infarction. Circulation. 1994;90:2103-2114.
11. Yarzebski J, Goldberg RJ, Gore JM, Alpert JS. Temporal trends and factors associated with extent of delay to hospital arrival in patients with acute myocardial infarction: The Worcester Heart Attack Study. Am Heart J. 1994;128:255-263.
12. Gurwitz JH, McLaughlin TJ, Willison DJ, et al. Delayed hospital presentation in patients who have had acute myocardial infarction. Ann Intern Med. 1997;126: 593-599.
13. Goldberg RJ, Gurwitz J, Yarzebski J, et al. Patient delay and receipt of thrombolytic therapy among patients with acute myocardial infarction from a community-wide perspective. Am J Cardiol. 1992;70:421-425.
14. Rowley JM, Hill JD, Hampton JR, Mitchell JR. Early reporting of myocardial infarction: impact of an experiment in patient education. BMJ. 1982;284:1741-1746.
15. Meischke H, Dulberg EM, Schaeffer SS, Henwood DK, Larsen MP, Eisenberg MS. "Call fast, call 911": a direct mail campaign to reduce patient delay in acute myocardial infarction. Am J Public Health. 1997;10:1705-1709.
16. Eppler E, Eisenberg MS, Schaeffer S, Meischke H, Larson MP. 911 and emergency department use for chest pain: results of a media campaign. Ann Emerg Med. 1994;24:202-208
17. Mitic WR, Perkins J. The effect of a media campaign on heart attack delay and decision times. Can J Public Health. 1984;75:414-418.
18. Ho MT, Eisenberg MS, Litwin PE, Schaeffer SM, Damon SK. Delay between onset of chest pain and seeking medical care: the effect of public education. Ann Emerg Med. 1989;18:727-731.
19. Herlitz J, Hartford M, Blohm M, et al. Effect of a media campaign on delay times and ambulance use in suspected acute myocardial infarction. Am J Cardiol. 1989; 64:90-93.
20. Herlitz J, Hartford M, Karlson BV, et al. Effect of a media campaign to reduce delay times tor acute myocardial infarction on the burden of chest pain patients in the emergency department. Cardiology. 1991;79:127-134.
21. Moses HW, Engelking N, Taylor GJ, et al. Effect of a two-year public education campaign on reducing response time of patients with symptoms of acute myocardial infarction. Am J Cardiol. 1991;68:249-251.
22. Gaspoz JM, Unger PF, Urban P, et al. Impact of a public campaign on pre-hospital delay in patients reporting chest pain. Heart. 1996;76:150-155.
23. Bett N, Aroney G, Thompson P. Impact on a national educational campaign to reduce patient delay in possible heart attack. Aust N Z J Med. 1993;23:157-161.
24. Simons-Morton DG, Goff DC, Osganian S, et al. Rapid early action for coronary treatment: rationale, design, and baseline characteristics. Acad Emerg Med. 1998; 5:726-738.